Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes

Purpose Mental well-being among community-dwelling individuals with type 2 diabetes has not been well established. The primary objective was to evaluate the change in the mental well-being of individuals with diabetes. The secondary objective was to evaluate the association between changes in mental...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Quality of life research 2019-12, Vol.28 (12), p.3273-3279
Hauptverfasser: Lum, Zheng Kang, Siaw, Melanie Yee Lee, Lee, Michelle Jia Xin, Koh, Zexuan, Zhang, Parry Quan, Eng, Soo Kiang, Tan, Swee Chin, Lee, Joyce Yu-Chia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3279
container_issue 12
container_start_page 3273
container_title Quality of life research
container_volume 28
creator Lum, Zheng Kang
Siaw, Melanie Yee Lee
Lee, Michelle Jia Xin
Koh, Zexuan
Zhang, Parry Quan
Eng, Soo Kiang
Tan, Swee Chin
Lee, Joyce Yu-Chia
description Purpose Mental well-being among community-dwelling individuals with type 2 diabetes has not been well established. The primary objective was to evaluate the change in the mental well-being of individuals with diabetes. The secondary objective was to evaluate the association between changes in mental well-being and perceived health over 6 months, and any interacting factors in this association. Methods This was a prospective, multicenter study. Community-dwelling individuals aged ≥ 21 years with type 2 diabetes were invited to meet with community pharmacists monthly for 6 months. Individuals who were unable to converse independently were excluded. A 12-item General Health Questionnaire (GHQ), measuring mental well-being was administered at baseline, and after 3 and 6 months. Perception of health was measured using the visual analog scale (VAS) of the EuroQoL 5-Dimension tool. Linear mixed model was used to analyze the change in mean GHQ and VAS scores. Association between the changes in GHQ and VAS scores was determined, and moderation analysis was conducted to elucidate the interacting variables of this association. Results Ninety-six individuals (82.4%) were included for analysis. The mean age was 60.3 years with a baseline mean HbA1c of 7.6%. A mean GHQ score reduction of 1.36 ( p  = 0.022) was observed. This reduction of mean GHQ score was associated with the change in mean VAS score. Having a duration of diabetes diagnosis of 
doi_str_mv 10.1007/s11136-019-02253-2
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2267022981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>48705253</jstor_id><sourcerecordid>48705253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-4302d45ddbf871033ec203491ed71ccca39cc8c6dee33c3ad8bf8d67c389e2553</originalsourceid><addsrcrecordid>eNp9kc1vVCEUxYnR2Gn1HzDRkLjpBgXu-2JpGj-aNHGja8LAnQ6TB-8JvDaz9D-X8dWauHAF5PzOuTccQl4J_k5w3r_PQgjoGBeKcSlbYPIJ2Yi2r5euUU_JhqtOMgUNnJHznA-c80Fx-ZycgYBWSRg25Od1mI0tdNrReW9SMBaX4q0ZqTUJ6RRpwFjq8x7HkW3Rx1tqoqMzJov-Dh3doxnLnpowVclOISzRlyNzJ8OJ9tH5O-8WM2Z67ytZjjNSSZ03WyyYX5Bnu6rhy4fzgnz_9PHb1Rd28_Xz9dWHG2ZB9YU1wKVrWue2u6EXHACt5NAoga4X1loDytrBdg4RwIJxQwVd11sYFMq2hQtyuebOafqxYC46-GzrkibitGQtZdfXb1SDqOjbf9DDtKRYtztRnVCik0Ol5ErZNOWccKfn5INJRy24PhWk14J0LUj_LkjLanrzEL1sA7pHy59GKgArkKsUbzH9nf3f2Ner65DLlB5Tm6HnbSXgF29epqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2266191628</pqid></control><display><type>article</type><title>Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes</title><source>MEDLINE</source><source>JSTOR</source><source>SpringerLink Journals - AutoHoldings</source><creator>Lum, Zheng Kang ; Siaw, Melanie Yee Lee ; Lee, Michelle Jia Xin ; Koh, Zexuan ; Zhang, Parry Quan ; Eng, Soo Kiang ; Tan, Swee Chin ; Lee, Joyce Yu-Chia</creator><creatorcontrib>Lum, Zheng Kang ; Siaw, Melanie Yee Lee ; Lee, Michelle Jia Xin ; Koh, Zexuan ; Zhang, Parry Quan ; Eng, Soo Kiang ; Tan, Swee Chin ; Lee, Joyce Yu-Chia</creatorcontrib><description>Purpose Mental well-being among community-dwelling individuals with type 2 diabetes has not been well established. The primary objective was to evaluate the change in the mental well-being of individuals with diabetes. The secondary objective was to evaluate the association between changes in mental well-being and perceived health over 6 months, and any interacting factors in this association. Methods This was a prospective, multicenter study. Community-dwelling individuals aged ≥ 21 years with type 2 diabetes were invited to meet with community pharmacists monthly for 6 months. Individuals who were unable to converse independently were excluded. A 12-item General Health Questionnaire (GHQ), measuring mental well-being was administered at baseline, and after 3 and 6 months. Perception of health was measured using the visual analog scale (VAS) of the EuroQoL 5-Dimension tool. Linear mixed model was used to analyze the change in mean GHQ and VAS scores. Association between the changes in GHQ and VAS scores was determined, and moderation analysis was conducted to elucidate the interacting variables of this association. Results Ninety-six individuals (82.4%) were included for analysis. The mean age was 60.3 years with a baseline mean HbA1c of 7.6%. A mean GHQ score reduction of 1.36 ( p  = 0.022) was observed. This reduction of mean GHQ score was associated with the change in mean VAS score. Having a duration of diabetes diagnosis of &lt; 3.2 years was identified as moderator of this association. Conclusion Effective integrated pharmaceutical care with individualized counseling on lifestyle management appeared to improve the mental health of community-dwelling individuals with diabetes on top of glycemic control.</description><identifier>ISSN: 0962-9343</identifier><identifier>EISSN: 1573-2649</identifier><identifier>DOI: 10.1007/s11136-019-02253-2</identifier><identifier>PMID: 31359238</identifier><language>eng</language><publisher>Cham: Springer Science + Business Media</publisher><subject>Adult ; Aged ; Blood Glucose - analysis ; CLINICAL AND POLICY APPLICATIONS ; Diabetes ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - psychology ; Female ; Glycated Hemoglobin A - analysis ; Humans ; Independent Living ; Life Style ; Male ; Medicine ; Medicine &amp; Public Health ; Mental Health - statistics &amp; numerical data ; Middle Aged ; Pharmaceutical Services ; Prospective Studies ; Public Health ; Quality of Life - psychology ; Quality of Life Research ; Sociology ; Surveys and Questionnaires ; Visual Analog Scale ; Well being ; Young Adult</subject><ispartof>Quality of life research, 2019-12, Vol.28 (12), p.3273-3279</ispartof><rights>Springer Nature Switzerland AG 2019</rights><rights>Quality of Life Research is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-4302d45ddbf871033ec203491ed71ccca39cc8c6dee33c3ad8bf8d67c389e2553</citedby><cites>FETCH-LOGICAL-c397t-4302d45ddbf871033ec203491ed71ccca39cc8c6dee33c3ad8bf8d67c389e2553</cites><orcidid>0000-0003-0515-9742</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/48705253$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/48705253$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27923,27924,41487,42556,51318,58016,58249</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31359238$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lum, Zheng Kang</creatorcontrib><creatorcontrib>Siaw, Melanie Yee Lee</creatorcontrib><creatorcontrib>Lee, Michelle Jia Xin</creatorcontrib><creatorcontrib>Koh, Zexuan</creatorcontrib><creatorcontrib>Zhang, Parry Quan</creatorcontrib><creatorcontrib>Eng, Soo Kiang</creatorcontrib><creatorcontrib>Tan, Swee Chin</creatorcontrib><creatorcontrib>Lee, Joyce Yu-Chia</creatorcontrib><title>Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes</title><title>Quality of life research</title><addtitle>Qual Life Res</addtitle><addtitle>Qual Life Res</addtitle><description>Purpose Mental well-being among community-dwelling individuals with type 2 diabetes has not been well established. The primary objective was to evaluate the change in the mental well-being of individuals with diabetes. The secondary objective was to evaluate the association between changes in mental well-being and perceived health over 6 months, and any interacting factors in this association. Methods This was a prospective, multicenter study. Community-dwelling individuals aged ≥ 21 years with type 2 diabetes were invited to meet with community pharmacists monthly for 6 months. Individuals who were unable to converse independently were excluded. A 12-item General Health Questionnaire (GHQ), measuring mental well-being was administered at baseline, and after 3 and 6 months. Perception of health was measured using the visual analog scale (VAS) of the EuroQoL 5-Dimension tool. Linear mixed model was used to analyze the change in mean GHQ and VAS scores. Association between the changes in GHQ and VAS scores was determined, and moderation analysis was conducted to elucidate the interacting variables of this association. Results Ninety-six individuals (82.4%) were included for analysis. The mean age was 60.3 years with a baseline mean HbA1c of 7.6%. A mean GHQ score reduction of 1.36 ( p  = 0.022) was observed. This reduction of mean GHQ score was associated with the change in mean VAS score. Having a duration of diabetes diagnosis of &lt; 3.2 years was identified as moderator of this association. Conclusion Effective integrated pharmaceutical care with individualized counseling on lifestyle management appeared to improve the mental health of community-dwelling individuals with diabetes on top of glycemic control.</description><subject>Adult</subject><subject>Aged</subject><subject>Blood Glucose - analysis</subject><subject>CLINICAL AND POLICY APPLICATIONS</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - psychology</subject><subject>Female</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Humans</subject><subject>Independent Living</subject><subject>Life Style</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mental Health - statistics &amp; numerical data</subject><subject>Middle Aged</subject><subject>Pharmaceutical Services</subject><subject>Prospective Studies</subject><subject>Public Health</subject><subject>Quality of Life - psychology</subject><subject>Quality of Life Research</subject><subject>Sociology</subject><subject>Surveys and Questionnaires</subject><subject>Visual Analog Scale</subject><subject>Well being</subject><subject>Young Adult</subject><issn>0962-9343</issn><issn>1573-2649</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc1vVCEUxYnR2Gn1HzDRkLjpBgXu-2JpGj-aNHGja8LAnQ6TB-8JvDaz9D-X8dWauHAF5PzOuTccQl4J_k5w3r_PQgjoGBeKcSlbYPIJ2Yi2r5euUU_JhqtOMgUNnJHznA-c80Fx-ZycgYBWSRg25Od1mI0tdNrReW9SMBaX4q0ZqTUJ6RRpwFjq8x7HkW3Rx1tqoqMzJov-Dh3doxnLnpowVclOISzRlyNzJ8OJ9tH5O-8WM2Z67ytZjjNSSZ03WyyYX5Bnu6rhy4fzgnz_9PHb1Rd28_Xz9dWHG2ZB9YU1wKVrWue2u6EXHACt5NAoga4X1loDytrBdg4RwIJxQwVd11sYFMq2hQtyuebOafqxYC46-GzrkibitGQtZdfXb1SDqOjbf9DDtKRYtztRnVCik0Ol5ErZNOWccKfn5INJRy24PhWk14J0LUj_LkjLanrzEL1sA7pHy59GKgArkKsUbzH9nf3f2Ner65DLlB5Tm6HnbSXgF29epqg</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Lum, Zheng Kang</creator><creator>Siaw, Melanie Yee Lee</creator><creator>Lee, Michelle Jia Xin</creator><creator>Koh, Zexuan</creator><creator>Zhang, Parry Quan</creator><creator>Eng, Soo Kiang</creator><creator>Tan, Swee Chin</creator><creator>Lee, Joyce Yu-Chia</creator><general>Springer Science + Business Media</general><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0515-9742</orcidid></search><sort><creationdate>20191201</creationdate><title>Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes</title><author>Lum, Zheng Kang ; Siaw, Melanie Yee Lee ; Lee, Michelle Jia Xin ; Koh, Zexuan ; Zhang, Parry Quan ; Eng, Soo Kiang ; Tan, Swee Chin ; Lee, Joyce Yu-Chia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-4302d45ddbf871033ec203491ed71ccca39cc8c6dee33c3ad8bf8d67c389e2553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Blood Glucose - analysis</topic><topic>CLINICAL AND POLICY APPLICATIONS</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - psychology</topic><topic>Female</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Humans</topic><topic>Independent Living</topic><topic>Life Style</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mental Health - statistics &amp; numerical data</topic><topic>Middle Aged</topic><topic>Pharmaceutical Services</topic><topic>Prospective Studies</topic><topic>Public Health</topic><topic>Quality of Life - psychology</topic><topic>Quality of Life Research</topic><topic>Sociology</topic><topic>Surveys and Questionnaires</topic><topic>Visual Analog Scale</topic><topic>Well being</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lum, Zheng Kang</creatorcontrib><creatorcontrib>Siaw, Melanie Yee Lee</creatorcontrib><creatorcontrib>Lee, Michelle Jia Xin</creatorcontrib><creatorcontrib>Koh, Zexuan</creatorcontrib><creatorcontrib>Zhang, Parry Quan</creatorcontrib><creatorcontrib>Eng, Soo Kiang</creatorcontrib><creatorcontrib>Tan, Swee Chin</creatorcontrib><creatorcontrib>Lee, Joyce Yu-Chia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (ProQuest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Quality of life research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lum, Zheng Kang</au><au>Siaw, Melanie Yee Lee</au><au>Lee, Michelle Jia Xin</au><au>Koh, Zexuan</au><au>Zhang, Parry Quan</au><au>Eng, Soo Kiang</au><au>Tan, Swee Chin</au><au>Lee, Joyce Yu-Chia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes</atitle><jtitle>Quality of life research</jtitle><stitle>Qual Life Res</stitle><addtitle>Qual Life Res</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>28</volume><issue>12</issue><spage>3273</spage><epage>3279</epage><pages>3273-3279</pages><issn>0962-9343</issn><eissn>1573-2649</eissn><abstract>Purpose Mental well-being among community-dwelling individuals with type 2 diabetes has not been well established. The primary objective was to evaluate the change in the mental well-being of individuals with diabetes. The secondary objective was to evaluate the association between changes in mental well-being and perceived health over 6 months, and any interacting factors in this association. Methods This was a prospective, multicenter study. Community-dwelling individuals aged ≥ 21 years with type 2 diabetes were invited to meet with community pharmacists monthly for 6 months. Individuals who were unable to converse independently were excluded. A 12-item General Health Questionnaire (GHQ), measuring mental well-being was administered at baseline, and after 3 and 6 months. Perception of health was measured using the visual analog scale (VAS) of the EuroQoL 5-Dimension tool. Linear mixed model was used to analyze the change in mean GHQ and VAS scores. Association between the changes in GHQ and VAS scores was determined, and moderation analysis was conducted to elucidate the interacting variables of this association. Results Ninety-six individuals (82.4%) were included for analysis. The mean age was 60.3 years with a baseline mean HbA1c of 7.6%. A mean GHQ score reduction of 1.36 ( p  = 0.022) was observed. This reduction of mean GHQ score was associated with the change in mean VAS score. Having a duration of diabetes diagnosis of &lt; 3.2 years was identified as moderator of this association. Conclusion Effective integrated pharmaceutical care with individualized counseling on lifestyle management appeared to improve the mental health of community-dwelling individuals with diabetes on top of glycemic control.</abstract><cop>Cham</cop><pub>Springer Science + Business Media</pub><pmid>31359238</pmid><doi>10.1007/s11136-019-02253-2</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-0515-9742</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0962-9343
ispartof Quality of life research, 2019-12, Vol.28 (12), p.3273-3279
issn 0962-9343
1573-2649
language eng
recordid cdi_proquest_miscellaneous_2267022981
source MEDLINE; JSTOR; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Blood Glucose - analysis
CLINICAL AND POLICY APPLICATIONS
Diabetes
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - psychology
Female
Glycated Hemoglobin A - analysis
Humans
Independent Living
Life Style
Male
Medicine
Medicine & Public Health
Mental Health - statistics & numerical data
Middle Aged
Pharmaceutical Services
Prospective Studies
Public Health
Quality of Life - psychology
Quality of Life Research
Sociology
Surveys and Questionnaires
Visual Analog Scale
Well being
Young Adult
title Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A49%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20pharmaceutical%20care%20on%20mental%20well-being%20and%20perceived%20health%20among%20community-dwelling%20individuals%20with%20type%202%20diabetes&rft.jtitle=Quality%20of%20life%20research&rft.au=Lum,%20Zheng%20Kang&rft.date=2019-12-01&rft.volume=28&rft.issue=12&rft.spage=3273&rft.epage=3279&rft.pages=3273-3279&rft.issn=0962-9343&rft.eissn=1573-2649&rft_id=info:doi/10.1007/s11136-019-02253-2&rft_dat=%3Cjstor_proqu%3E48705253%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2266191628&rft_id=info:pmid/31359238&rft_jstor_id=48705253&rfr_iscdi=true